Aker BioMarine AS announced that the company expects higher growth compared to the second quarter last year, but also expecting sales to be on par or higher than this quarter, the first quarter of 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.3 NOK | -1.79% | +0.56% | +55.00% |
Apr. 26 | Aker BioMarine AS Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 26 | Transcript : Aker BioMarine AS, Q1 2024 Earnings Call, Apr 26, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.00% | 566M | |
+12.78% | 3.29B | |
-95.58% | 1.61B | |
-0.48% | 1.61B | |
-2.37% | 1.25B | |
-2.40% | 1.22B | |
-.--% | 1.22B | |
-11.54% | 1.21B | |
-10.44% | 1.2B | |
0.00% | 1.19B |
- Stock Market
- Equities
- AKBM Stock
- News Aker BioMarine
- Aker BioMarine AS Provides Sales Guidance for the Second Quarter of 2023